Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Stallergenes S a
Stallergenes
Stallergenes Sa

Stallergenes patents


Recent patent applications related to Stallergenes. Stallergenes is listed as an Agent/Assignee. Note: Stallergenes may have other listings under different names/spellings. We're not affiliated with Stallergenes, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Stallergenes-related inventors


Sialylated fetuin-a as a marker of immunotherapy efficacy

The invention concerns the identification of specific polypeptides, fragments variants thereof which can be used as markers for the efficacy of immunotherapy, particular for predicting responsiveness of a patient to immunotherapy.. . ... Stallergenes

Markers of immune response

The present invention concerns methods for determining if a dendritic cell is a type 2 dendritic cell or a tolerogenic dendritic cell, methods for determining if a patient undergoing immunotherapy, and/or who has been administered with a vaccine, is developing an immune response oriented either towards a regulatory t cell response or towards an effector type 2 cell response, and methods of determining response to immunotherapy.. . ... Stallergenes

Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids

The invention relates to grass pollen extracts containing reduced amount of flavonoid glycosides in order to minimize the risks of genotoxicity of the grass pollen extracts. The invention also relates to a method of preparing grass pollen extracts containing reduced amount of flavonoid glycosides by ultrafiltration. ... Stallergenes

Composition of allergen extracts having reduced toxicity and method of production thereof

The present invention concerns pollen allergen extracts, in particular ragweed (ambrosia) pollen allergen extracts, containing reduced amounts of copper-binding-like proteins in order to minimize the risk of toxicity, including induction of angioedema, of those allergen extracts. The invention also relates to methods of preparing pollen allergen extracts containing reduced amounts of copper-binding-like proteins.. ... Stallergenes

Compositions for antigen-specific induction of tolerance

The invention relates to an immunogenic composition far sublingual, perlingual or oral administration, comprising at least an antigen and at least an adjuvant that is a bacterium selected from a bifidobacterium and a lactic acid bacterium, and or a combination of a corticosteroid with vitamin d3 or any metabolite or analog of the latter, in a pharmaceutically acceptable carrier that is suitable tor sublingual, perlingual, or oral administration. Such compositions allow to elicit antigen-specific immune tolerance.. ... Stallergenes








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Stallergenes in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Stallergenes with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###